Abstract:Stroke is the second highest disease causing burden on the global economy and one of the leading causes of non-traumatic disability [ [1] Murray C.J. Lopez A.D. Measuring the global burden of disease[J]. N Engl J Med. 2013; 369: 448-457https://doi.org/10.1056/NEJMra1201534 Crossref PubMed Scopus (1151) Google Scholar ]. As many as 30–40% of ischemic stroke cases have no identified medical cause, known as cryptogenic stroke (CS) [ [2] Hart R.G. Diener H.C. Coutts S.B. et al. Embolic strokes of undetermined source: the case for a new clinical construct[J]. Lancet Neurol. 2014; 13: 429-438https://doi.org/10.1016/S1474-4422(13)70310-7 Abstract Full Text Full Text PDF PubMed Scopus (916) Google Scholar ]. Within the last century, the incidence of patent foramen ovale (PFO) in patients with CS is as high as 50–60%, which is significantly higher than 20–30% in the normal population [ [3] Hara H. Virmani R. Ladich E. et al. Patent foramen ovale: current pathology, pathophysiology, and clinical status[J]. J Am Coll Cardiol. 2005; 46: 1768-1776https://doi.org/10.1016/j.jacc.2005.08.038 Crossref PubMed Scopus (230) Google Scholar ]. In the past two decades, to explore the effective treatment of patients with CS and PFO, several related experiments have been conducted in the academic community. After contradictory views and negative results, it was finally confirmed that closure therapy can significantly reduce the risk of stroke recurrence [ 4 Mas J.L. Derumeaux G. Guillon B. et al. Patent foramen ovale closure or anticoagulation vs. antiplatelets after stroke[J]. N Engl J Med. 2017; 377: 1011-1021https://doi.org/10.1056/NEJMoa1705915 Crossref PubMed Scopus (565) Google Scholar , 5 Saver J.L. Carroll J.D. Thaler D.E. et al. Long-Term outcomes of patent foramen ovale closure or medical therapy after stroke[j]. N Engl J Med. 2017; 377: 1022-1032https://doi.org/10.1056/NEJMoa1610057 Crossref PubMed Scopus (531) Google Scholar , 6 Søndergaard L. Kasner S.E. Rhodes J.F. et al. Patent foramen ovale closure or antiplatelet therapy for cryptogenic stroke[j]. New England Journal of Medicine. 2017; 377: 1033-1042https://doi.org/10.1056/NEJMoa1707404 Crossref PubMed Scopus (554) Google Scholar ]. However, literature on the Asian population with a high incidence of stroke, particularly on biomarkers for risk factors for stroke recurrence, is currently lacking.

Clinical and Infarction Patterns of PFO‐related Cryptogenic Strokes and a Prediction Model

Intelligent Prediction of Cryptogenic Stroke Using Patent Foramen Ovale from TEE Imaging Data and Machine Learning Methods

Change in Patent Foramen Ovale Height is Associated with Cryptogenic Stroke and the Construction of a Morphology-Based Scoring System

Assessment of the Characteristics of Patent Foramen Ovale Associated with Cryptogenic Stroke

Closing Patent Foramen Ovale in Cryptogenic Stroke: the Underscored Importance of Other Interatrial Shunt Variants

Machine Learning in a Real-World PFO Study: Analysis of Data from Multi-Centers in China.

Relation Between Cryptogenic Ischemic Stroke and Patent Foramen Ovale in Young and Middle-Aged Adults

Comparison of Stroke Recurrence Between Antiplatelet and Closure Therapy in Cryptogenic Stroke Patients with Patent Foramen Ovale and Its Influencing Factors

Development and Validation of an Individualized Nomogram for Predicting Patent Foramen Ovale‐Associated Stroke: Patent Foramen Ovale Morphology‐Based Analysis

Research progress in Patent foramen ovale and cryptogenic stroke

The current issue of paradoxical embolism and cryptogenic stroke

Increased Blood Residence Time As Markers of High-Risk Patent Foramen Ovale.

Comparison of atrial septal defect and patent foramen ovale in cryptogenic strokes

Percutaneous Patent Foramen Ovale Closure in Patients with Cryptogenic Stroke or Transient Ischemic Attack: A Retrospective Study.

Ignored Role of Paroxysmal Atrial Fibrillation in the Pathophysiology of Cryptogenic Stroke in Patients with Patent Foramen Ovale and Atrial Septal Aneurysm

Propensity-score matched analysis of patent foramen ovale closure in real-world study cohort with cryptogenic ischemic stroke

Research Progress of Paroxysmal Atrial Fibrillation and Cryptogenic Stroke

Diagnosis and treatment of 2 cases with cryptogenic stroke due to patent foramen ovale in children: A case report

Management of Patients with Patent Foramen Ovale and Cryptogenic Stroke: a Collaborative, Multidisciplinary, Position Paper.

0205: Comparison of Patent Foramen Ovale and Aortic Atherosclerosis in Patients with Cryptogenic Ischemic Stroke or Transient Ischemic Attack

Comparison of frequencies of patent foramen ovale and thoracic aortic atherosclerosis in patients with cryptogenic ischemic stroke undergoing transesophageal echocardiography.